317 related articles for article (PubMed ID: 33262518)
1. Metformin use and lung cancer survival: a population-based study in Norway.
Brancher S; Støer NC; Weiderpass E; Damhuis RAM; Johannesen TB; Botteri E; Strand TE
Br J Cancer; 2021 Mar; 124(5):1018-1025. PubMed ID: 33262518
[TBL] [Abstract][Full Text] [Related]
2. Prediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the VITAL study.
Brasky TM; Baik CS; Slatore CG; Alvarado M; White E
J Thorac Oncol; 2012 Oct; 7(10):1503-12. PubMed ID: 22982651
[TBL] [Abstract][Full Text] [Related]
3. Survival Comparison in Patients with Stage IV Lung Cancer in Academic versus Community Centers in the United States.
Ramalingam S; Dinan MA; Crawford J
J Thorac Oncol; 2018 Dec; 13(12):1842-1850. PubMed ID: 30312680
[TBL] [Abstract][Full Text] [Related]
4. Retrospective Study of the Effect of Statins on the Outcome of Lung Cancer Patients, University of Cincinnati Experience.
Gaber O; Eldessouki I; Hassan R; Magdy M; Morris JC; Abdel Karim N
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2391-2396. PubMed ID: 31450911
[TBL] [Abstract][Full Text] [Related]
5. Real world utilization of EGFR TKIs and prognostic factors for survival in NSCLC during 2010-2016 in Sweden: A nationwide observational study.
Bergqvist M; Christensen HN; Wiklund F; Bergström S
Int J Cancer; 2020 May; 146(9):2510-2517. PubMed ID: 31350754
[TBL] [Abstract][Full Text] [Related]
6. Non-small Cell Lung Cancer as a Chronic Disease - A Prospective Study from the Czech TULUNG Registry.
Bratova M; Karlinova B; Skrickova J; Pesek M; Kolek V; Koubkova L; Hrnciarik M; Krejci J; Barinova M; Havel L; Grygarkova I; Brat K
In Vivo; 2020; 34(1):369-379. PubMed ID: 31882501
[TBL] [Abstract][Full Text] [Related]
7. Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival.
Barczi E; Nagy T; Starobinski L; Kolonics-Farkas A; Eszes N; Bohacs A; Tarnoki AD; Tarnoki DL; Müller V
Thorac Cancer; 2020 Jul; 11(7):1911-1917. PubMed ID: 32401433
[TBL] [Abstract][Full Text] [Related]
8. Impact of Age on Outcomes with Immunotherapy in Patients with Non-Small Cell Lung Cancer.
Lichtenstein MRL; Nipp RD; Muzikansky A; Goodwin K; Anderson D; Newcomb RA; Gainor JF
J Thorac Oncol; 2019 Mar; 14(3):547-552. PubMed ID: 30476576
[TBL] [Abstract][Full Text] [Related]
9. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
[TBL] [Abstract][Full Text] [Related]
10. Factors Associated With Survival in Complete Pathologic Response Non-Small Cell Lung Cancer.
Martinez-Meehan D; Lutfi W; Dhupar R; Christie N; Baker N; Schuchert M; Luketich JD; Okusanya OT
Clin Lung Cancer; 2020 Jul; 21(4):349-356. PubMed ID: 32299769
[TBL] [Abstract][Full Text] [Related]
11. Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.
National Lung Screening Trial Research Team
J Thorac Oncol; 2019 Oct; 14(10):1732-1742. PubMed ID: 31260833
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysis.
Malhotra J; Mhango G; Gomez JE; Smith C; Galsky MD; Strauss GM; Wisnivesky JP
Ann Oncol; 2015 Apr; 26(4):768-773. PubMed ID: 25600562
[TBL] [Abstract][Full Text] [Related]
13. Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors.
Hendriks LEL; Henon C; Auclin E; Mezquita L; Ferrara R; Audigier-Valette C; Mazieres J; Lefebvre C; Rabeau A; Le Moulec S; Cousin S; Duchemann B; le Pechoux C; Botticella A; Ammari S; Gazzah A; Caramella C; Adam J; Lechapt E; Planchard D; De Ruysscher D; Dingemans AM; Besse B
J Thorac Oncol; 2019 Jul; 14(7):1244-1254. PubMed ID: 30780002
[TBL] [Abstract][Full Text] [Related]
14. The Care and Outcomes of Older Persons with Lung Cancer in England and the United States, 2008-2012.
Andreano A; Peake MD; Janes SM; Valsecchi MG; Pritchard-Jones K; Hoag JR; Gross CP
J Thorac Oncol; 2018 Jul; 13(7):904-914. PubMed ID: 29727739
[TBL] [Abstract][Full Text] [Related]
15. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
[TBL] [Abstract][Full Text] [Related]
16. Genetic Investigation of Polymorphic OGG1 and MUTYH Genes Towards Increased Susceptibility in Lung Adenocarcinoma and its Impact on Overall Survival of Lung Cancer Patients Treated with Platinum Based Chemotherapy.
Singh A; Singh N; Behera D; Sharma S
Pathol Oncol Res; 2019 Oct; 25(4):1327-1340. PubMed ID: 29209987
[TBL] [Abstract][Full Text] [Related]
17. Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma.
Qu Y; Emoto K; Eguchi T; Aly RG; Zheng H; Chaft JE; Tan KS; Jones DR; Kris MG; Adusumilli PS; Travis WD
J Thorac Oncol; 2019 Mar; 14(3):482-493. PubMed ID: 30503889
[TBL] [Abstract][Full Text] [Related]
18. A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer.
Paz-Ares L; Bálint B; de Boer RH; van Meerbeeck JP; Wierzbicki R; De Souza P; Galimi F; Haddad V; Sabin T; Hei YJ; Pan Y; Cottrell S; Hsu CP; RamLau R
J Thorac Oncol; 2013 Mar; 8(3):329-37. PubMed ID: 23370314
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for non-small cell lung cancer: practice patterns and outcomes in the general population of Ontario, Canada.
Booth CM; Shepherd FA; Peng Y; Darling G; Li G; Kong W; Mackillop WJ
J Thorac Oncol; 2012 Mar; 7(3):559-66. PubMed ID: 22307012
[TBL] [Abstract][Full Text] [Related]
20. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS
J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
